Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midostaurin in FLT3-ITD Positive AML (AMLSG 16-10)
NCT01477606Phase 2Completed
- Sponsor
- Ulm University
- Start
- May 2012
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of midostaurin in acute myeloid leukemia (AML), sponsored by Ulm University. Started May 2012; status: completed.
02
Drugs
midostaurin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01477606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01477606.